Pharmacogenetics of Immunosuppressants: Progress, Pitfalls and Promises
Open Access
- 1 July 2008
- journal article
- review article
- Published by Elsevier in American Journal of Transplantation
- Vol. 8 (7) , 1374-1383
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantationExpert Opinion on Pharmacotherapy, 2007
- Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal TransplantationJournal of the American Society of Nephrology, 2007
- Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant RecipientsClinical Pharmacokinetics, 2007
- The MDR1/ABCB1 Gene, a High-Impact Risk Factor for Cardiac Transplant RejectionTransplantation, 2006
- Tacrolimus dose requirement in relation to donor and recipientABCB1 andCYP3A5 gene polymorphisms in Chinese liver transplant patientsLiver Transplantation, 2006
- Sirolimus Population Pharmacokinetic/Pharmacogenetic Analysis and Bayesian Modelling in Kidney Transplant RecipientsClinical Pharmacokinetics, 2006
- Identification of a novel 5–base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophyAmerican Heart Journal, 2005
- Pharmacokinetic Principles of Immunosuppressive DrugsAmerican Journal of Transplantation, 2005
- AZATHIOPRINE-INDUCED FATAL MYELOSUPPRESSION IN A RENAL-TRANSPLANT RECIPIENT WHO CARRIED HETEROZYGOUS TPMT*1/*3CTransplantation, 2003
- Azathioprine Pharmacogenetics: The Relationship between 6-Thioguanine Nucleotides and Thiopurine Methyltransferase in Patients after Heart and Kidney TransplantationClinical Chemistry and Laboratory Medicine (CCLM), 1996